These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 5673392)
1. Use and abuse of advertising in medicine. Advertising and the pattern of prescribing. Teeling-Smith G Proc R Soc Med; 1968 Aug; 61(8):748-50. PubMed ID: 5673392 [No Abstract] [Full Text] [Related]
2. [Can physicians rely upon the drug information?]. Hansson O Nord Med; 1976 Jun; 91(6-7-1):193. PubMed ID: 934796 [No Abstract] [Full Text] [Related]
3. Economic problems in drug distribution. Rucker TD Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974 [No Abstract] [Full Text] [Related]
4. Drug advertising. Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920 [No Abstract] [Full Text] [Related]
5. The relationship of the technical staff of the pharmaceutical industry to its promotional activities. Proc R Soc Med; 1968 Aug; 61(8):743-7. PubMed ID: 5673391 [No Abstract] [Full Text] [Related]
6. Prescribing pressure. Krasner DM Del Med J; 1990 May; 62(5):1029. PubMed ID: 2344894 [No Abstract] [Full Text] [Related]
7. The suboptimal legibility of prescribing information in pharmaceutical advertisements. Lohiya S; Lohiya S J Am Board Fam Med; 2007; 20(3):314-5. PubMed ID: 17478666 [No Abstract] [Full Text] [Related]
8. Distinctions with little difference: pseudo-competition in the pharmaceutical industry. Drug Ther Bull; 1976 Jul; 14(14):53-4. PubMed ID: 964128 [No Abstract] [Full Text] [Related]
9. [Letter: Advertising for Ponderal]. Persson I Ugeskr Laeger; 1973 Nov; 135(45):2471. PubMed ID: 4773734 [No Abstract] [Full Text] [Related]
10. [Critical reflections on the concept "drug advertising" regarding the marketing of the drug Ponderal (fenfluramine)]. Schjott F Ugeskr Laeger; 1973 Sep; 135(36):1958-61. PubMed ID: 4774003 [No Abstract] [Full Text] [Related]
11. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical promotion and its impact on the practice of medicine. HAINES TF J Med Assoc State Ala; 1963 Apr; 32():310-4. PubMed ID: 13951989 [No Abstract] [Full Text] [Related]
13. [Resisting drug propaganda]. Kalsbeek F Ned Tijdschr Geneeskd; 1973 Jan; 117(4):141-5. PubMed ID: 4683811 [No Abstract] [Full Text] [Related]
14. [Drug abuse: bluff or reality?]. Jaminet F Rev Med Liege; 1977 May; 32(10):297-316. PubMed ID: 887879 [No Abstract] [Full Text] [Related]
16. Code of fair practices in the promotion of drug products. Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133 [No Abstract] [Full Text] [Related]
17. [Industry has almost monopoly on information]. Lie A Nord Med; 1976 Jun; 91(6-7-1):194. PubMed ID: 934797 [No Abstract] [Full Text] [Related]
18. Peddling drugs to docs. Heussner RC Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331 [No Abstract] [Full Text] [Related]
19. Advertising and abuse of drugs. Seidenberg R N Engl J Med; 1971 Apr; 284(14):789-90. PubMed ID: 5102199 [No Abstract] [Full Text] [Related]
20. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?]. Eckardt VF Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695 [No Abstract] [Full Text] [Related] [Next] [New Search]